The American Journal of Managed Care > November 2008 - Special Issue
The American Journal of Managed Care - November 2008 - Special Issue
November 15, 2008 – Andrew J. Epstein, PhD, MPP; Saif S. Rathore, MPH; G. Caleb Alexander, MD; and Jonathan D. Ketcham, PhD
Primary care physicians have mixed views of prescription drug coverage under Medicare Part D.
November 15, 2008 – Kenneth E. Thorpe, PhD
November 15, 2008 – Jonathan D. Ketcham, PhD; and Kosali I. Simon, PhD
As a result of Medicare Part D, elderly patients' out-of-pocket costs for prescription drugs decreased and their utilization increased, mostly from 2005-2006.
November 15, 2008 – Bryan R. Cote, MA; and Elizabeth A. Petersen, MA
Switching medications for nonmedical (formulary) reasons in long-term care settings may increase Medicare Part D resident adverse effects and raise facility downstream costs.
November 15, 2008 – E. Anne Jackson, BS; and Kirsten J. Axelsen, MS
Analysis of Medicare Part D formulary composition since program inception suggests beneficiaries may not be using their open-enrollment periods to reevaluate available plan offerings.
November 15, 2008 – Carrie McAdam-Marx, RPh, MS; David T. Schaaf, MD; Anke-Peggy Holtorf, PhD, MBA; Benjamin Eng, MD; and Gary M. Oderda, PharmD, MPH
Adopting quality measurement standards for drug management programs might increase the effectiveness and long-term sustainability of positive health outcomes for patients.
November 15, 2008 – Jonathan D. Ketcham, PhD; and Jeffrey K. Ngai, MBA, MHSM
Comparison of the generosity and consistency of 10 states' Medicaid preferred drug lists for the top therapeutic classes revealed a large degree of inconsistency.